Stock comparison
Eli Lilly
McKesson
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$946.37B
Sector
Healthcare
MCK
McKesson
Market cap
$91.42B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | MCK | Winner |
|---|---|---|---|
| Warren Buffett | 65B | 57C | LLY |
| Benjamin Graham | 76B | 28F | LLY |
| Philip Fisher | 75B | 43D | LLY |
| Peter Lynch | 64C | 39D | LLY |
| Joel Greenblatt | 68B | 46D | LLY |
| Charlie Munger | 75B | 36D | LLY |
| Terry Smith | 66B | 49D | LLY |
Side-by-side metrics
| Metric | LLY | MCK |
|---|---|---|
| Market cap | $946.37B | $91.42B |
| P/E (TTM) | 35.6x | 19.5x |
| EV/EBIT | 33.2x | 14.9x |
| ROIC (TTM) | 32.06% | 31.07% |
| Gross margin | 83.51% | 3.61% |
| Net margin | 34.98% | 1.18% |
| Revenue CAGR 5y | 23.17% | 11.19% |
| EPS CAGR 5y | 40.81% | 51.54% |
| Debt / Equity | 1.4x | - |
| Dividend yield | 0.64% | 0.42% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- Net margin34.98%vs 1.18%+97%
- Gross margin83.51%vs 3.61%+96%
- Market cap$946.37Bvs $91.42B+90%
- Revenue CAGR 5y23.17%vs 11.19%+52%
MCK leads on
- Debt / Equity-vs 1.4x+135%
- EV/EBIT14.9xvs 33.2x+55%
- P/E (TTM)19.5xvs 35.6x+45%
- EPS CAGR 5y51.54%vs 40.81%+21%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.